Výsledky vyhledávání

Akademický článek

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.

Autor: Sluder AE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Raju Paul S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Moise L; EpiVax, Inc., Providence, RI, United States., Dold C; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Richard G; EpiVax, Inc., Providence, RI, United States., Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Baeten LA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., Scholzen A; Innatoss Laboratories B.V., Oss, Netherlands., Reeves PM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Garritsen A; Innatoss Laboratories B.V., Oss, Netherlands., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., De Groot AS; EpiVax, Inc., Providence, RI, United States., Rollier C; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 May 16; Vol. 13, pp. 901372. Date of Electronic Publication: 2022 May 16 (Print Publication: 2022).

Zobrazit plný text záznamu

Akademický článek

Effects of Inactivated Mycobacterium bovis Vaccination on Molokai-Origin Wild Pigs Experimentally Infected with Virulent M. bovis .

Autor: Nol P; Centers for Epidemiology and Animal Health, Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Fort Collins, CO 80526, USA., Wehtje ME; Centers for Epidemiology and Animal Health, Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Fort Collins, CO 80526, USA.; Dinosaur National Monument, Dinosaur, CO 81610, USA., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Robbe-Austerman S; National Veterinary Services Laboratory, Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Ames, IA 50010, USA., Thacker TC; National Veterinary Services Laboratory, Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Ames, IA 50010, USA., Lantz K; National Veterinary Services Laboratory, Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Ames, IA 50010, USA., Rhyan JC; National Veterinary Services Laboratory, Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Fort Collins, CO 80521, USA., Baeten LA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.; National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection Service, United States Department of Agriculture Fort Collins, CO 80521, USA., Juste RA; NEIKER-Instituto Vasco de Investigación y Desarrollo Agrario, Animal Health Department, Derio, 48160 Bizkaia, Spain., Sevilla IA; NEIKER-Instituto Vasco de Investigación y Desarrollo Agrario, Animal Health Department, Derio, 48160 Bizkaia, Spain., Gortázar C; SaBio Instituto de Investigación en Recursos Cinegéticos IREC, University Castilla la Mancha & CSIC, 13003 Ciudad Real, Spain., Vicente J; SaBio Instituto de Investigación en Recursos Cinegéticos IREC, University Castilla la Mancha & CSIC, 13003 Ciudad Real, Spain.

Publikováno v: Pathogens (Basel, Switzerland) [Pathogens] 2020 Mar 07; Vol. 9 (3). Date of Electronic Publication: 2020 Mar 07.

Zobrazit plný text záznamu

Akademický článek

Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Autor: Scholzen A; InnatOss Laboratories B.V., Oss, Netherlands., Richard G; EpiVax, Inc., Providence, RI, United States., Moise L; EpiVax, Inc., Providence, RI, United States.; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States., Baeten LA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., Reeves PM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Martin WD; EpiVax, Inc., Providence, RI, United States., Brauns TA; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Boyle CM; EpiVax, Inc., Providence, RI, United States., Raju Paul S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Bucala R; Department of Medicine, Yale University School of Medicine, New Haven, CT, United States., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., Garritsen A; InnatOss Laboratories B.V., Oss, Netherlands., De Groot AS; EpiVax, Inc., Providence, RI, United States.; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States., Sluder AE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2019 Feb 15; Vol. 10, pp. 207. Date of Electronic Publication: 2019 Feb 15 (Print Publication: 2019).

Zobrazit plný text záznamu

Akademický článek

Standardized guinea pig model for Q fever vaccine reactogenicity.

Autor: Baeten LA; Colorado State University, Department of Biomedical Sciences, Fort Collins, Colorado, United States of America., Podell BK; Colorado State University, Department of Microbiology, Immunology and Pathology, Fort Collins, Colorado, United States of America., Sluder AE; Massachusetts General Hospital, Vaccine and Immunotherapy Center, Boston, Massachusetts, United States of America., Garritsen A; InnatOss Laboratories BV, Oss, Netherlands., Bowen RA; Colorado State University, Department of Biomedical Sciences, Fort Collins, Colorado, United States of America., Poznansky MC; Massachusetts General Hospital, Vaccine and Immunotherapy Center, Boston, Massachusetts, United States of America.

Publikováno v: PloS one [PLoS One] 2018 Oct 12; Vol. 13 (10), pp. e0205882. Date of Electronic Publication: 2018 Oct 12 (Print Publication: 2018).

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání